Multiple myeloma is the second most prevalent hematological malignancy, with over 55, 000 new cases diagnosed each year. This exciting new text, edited by lauded authorities on the topic, stands as the only available reference to assemble, review, and synthesizes the latest studies on translational therapies and clearly explains the impact of molecular pathogenesis, biology, and prognostic factors on the diagnosis, prognosis, and individualization of treatment and the development of novel therapeutic options for patients with myeloma.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.

At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.

Perlego offers two plans: Essential and Complete

Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.

Both plans are available with monthly, semester, or annual billing cycles.

We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.

Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.

Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.

Yes, you can access Multiple Myeloma by Kenneth C. Anderson,Irene Ghobrial, Kenneth C. Anderson, Irene Ghobrial in PDF and/or ePUB format, as well as other popular books in Medicine & Hematology. We have over one million books available in our catalogue for you to explore.

Information

Publisher

Year

Print ISBN

eBook ISBN

Edition

Topic

Medicine

Subtopic

Hematology

Front cover
Preface
Contents
Contributors
Chapter 1. Xenograft Animal Models for Preclinical Evaluation of Potential Anti-MM Therapeutics: Strengths and Limitations
Chapter 2. The Role of the Bone Marrow Microenvironment in the Pathogenesis of Multiple Myeloma
Chapter 3. Myeloma Bone Disease
Chapter 4. Niches Within the Multiple Myeloma Bone Marrow Microenvironment
Chapter 5. Novel Therapuetic Targets in Multiple Myeloma
Chapter 6. Monoclonal Gammopathy of Undetermined Significance
Chapter 7. Prognostic Factors and Classification in Multiple Myeloma
Chapter 8. Novel Agents for Previously Untreated Multiple Myeloma
Chapter 9. Novel Therapuetic Options for the Treatment of Relapsed and Relapsed, Refractory Myeloma
Chapter 10. High-Dose Therapy in Multiple Myeloma
Chapter 11. Promising New Agents in Phase I and II Clinical Trials in Multiple Myeloma
Chapter 12. Immunotheapeutic Strategies for the Management of Multiple Myeloma
Chapter 13. Novel Therapeutic Options in Primary Systemic Amyloidosis
Chapter 14. Novel Options of Therapy in Waldenstrom Macroglobulinemia
Index
Back cover

About this book

Frequently asked questions

Information

Table of contents